000566.SZ · 海南海药
China A-shares · RS rating 18 · As of 2026-10-14
| Price | 4.38 CNY |
|---|---|
| 1-day change | -2.7% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 27 / 37 / 35 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 22 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -9.0% |
| Distance from 52-week high | +50.0% |
| Market cap (USD) | $913.8M |